Scott N. Penfold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott N. Penfold has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Annabelle M. Austin
Department of Physics University of Adelaide Adelaide SA Australia
2 shared publications - Giang T. Nguyen
The University of Adelaide
2 shared publications - Michael John James Douglass
University of Adelaide and Royal Adelaide Hospital
2 shared publications - Eileen Giles
Allied Health and Human Performance University of South Australia Adelaide South Australia Australia
1 shared publication - Hien Le
Department of Radiation Oncology Royal Adelaide Hospital Adelaide South Australia Australia
1 shared publication Jiahua Zhu
Department of Physics, University of Adelaide, Adelaide, SA, 5005, Australia
1 shared publication
Latest Publications
- Open Access
- 8 April 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (4) , 282
Impact of Breast Size on Dosimetric Indices in Proton Versus X-ray Radiotherapy for Breast Cancer
Deep inspiration breath hold (DIBH) radiotherapy is a technique used to manage early stage left-sided breast cancer. This study compared dosimetric indices of patient-specific X-ray versus proton therapy DIBH plans to explore differences in target coverage, radiation doses to organs at risk, and the impact of breast size. Radiotherapy plans of sixteen breast cancer patients previously treated with DIBH radiotherapy were re-planned with hybrid inverse-planned intensity modulated X-ray radiotherapy (h-IMRT) and intensity modulated proton therapy (IMPT). The total prescribed dose was 40.05 Gy in 15 fractions for all cases. Comparisons between the clinical, h-IMRT, and IMPT evaluated doses to target volumes, organs at risk, and correlations between doses and breast size. Although no differences were observed in target volume coverage between techniques, the h-IMRT and IMPT were able to produce more even dose distributions and IMPT delivered significantly less dose to all organs at risk than both X-ray techniques. A moderate negative correlation was observed between breast size and dose to the target in X-ray techniques, but not IMPT. Both h-IMRT and IMPT produced plans with more homogeneous dose distribution than forward-planned IMRT and IMPT achieved significantly lower doses to organs at risk compared to X-ray techniques.
- 8 April 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (4) , 282
Open AccessImpact of Breast Size on Dosimetric Indices in Proton Versus X-ray Radiotherapy for Breast Cancer
Deep inspiration breath hold (DIBH) radiotherapy is a technique used to manage early stage left-sided breast cancer. This study compared dosimetric indices of patient-specific X-ray versus proton therapy DIBH plans to explore differences in target coverage, radiation doses to organs at risk, and the impact of breast size. Radiotherapy plans of sixteen breast cancer patients previously treated with DIBH radiotherapy were re-planned with hybrid inverse-planned intensity modulated X-ray radiotherapy (h-IMRT) and intensity modulated proton therapy (IMPT). The total prescribed dose was 40.05 Gy in 15 fractions for all cases. Comparisons between the clinical, h-IMRT, and IMPT evaluated doses to target volumes, organs at risk, and correlations between doses and breast size. Although no differences were observed in target volume coverage between techniques, the h-IMRT and IMPT were able to produce more even dose distributions and IMPT delivered significantly less dose to all organs at risk than both X-ray techniques. A moderate negative correlation was observed between breast size and dose to the target in X-ray techniques, but not IMPT. Both h-IMRT and IMPT produced plans with more homogeneous dose distribution than forward-planned IMRT and IMPT achieved significantly lower doses to organs at risk compared to X-ray techniques.
- 10 February 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (2) , 493-503
Patient selection for proton therapy: a radiobiological fuzzy Markov model incorporating robust plan analysis
While proton therapy can offer increased sparing of healthy tissue compared with X-ray therapy, it can be difficult to predict whether a benefit can be expected for an individual patient. Predictive modelling may aid in this respect. However, the predictions of these models can be affected by uncertainties in radiobiological model parameters and in planned dose. The aim of this work is to present a Markov model that incorporates these uncertainties to compare clinical outcomes for individualised proton and X-ray therapy treatments. A time-inhomogeneous fuzzy Markov model was developed which estimates the response of a patient to a given treatment plan in terms of quality adjusted life years. These are calculated using the dose-dependent probabilities of tumour control and toxicities as transition probabilities in the model. Dose-volume data representing multiple isotropic patient set-up uncertainties and range uncertainties (for proton therapy) are included to model dose delivery uncertainties. The model was retrospectively applied to an example patient as a demonstration. When uncertainty in the radiobiological model parameter was considered, the model predicted that proton therapy would result in an improved clinical outcome compared with X-ray therapy. However, when dose delivery uncertainty was included, there was no difference between the two treatments. By incorporating uncertainties in the predictive modelling calculations, the fuzzy Markov concept was found to be well suited to providing a more holistic comparison of individualised treatment outcomes for proton and X-ray therapy. This may prove to be useful in model-based patient selection strategies.
- 10 February 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (2) , 493-503
Patient selection for proton therapy: a radiobiological fuzzy Markov model incorporating robust plan analysis
While proton therapy can offer increased sparing of healthy tissue compared with X-ray therapy, it can be difficult to predict whether a benefit can be expected for an individual patient. Predictive modelling may aid in this respect. However, the predictions of these models can be affected by uncertainties in radiobiological model parameters and in planned dose. The aim of this work is to present a Markov model that incorporates these uncertainties to compare clinical outcomes for individualised proton and X-ray therapy treatments. A time-inhomogeneous fuzzy Markov model was developed which estimates the response of a patient to a given treatment plan in terms of quality adjusted life years. These are calculated using the dose-dependent probabilities of tumour control and toxicities as transition probabilities in the model. Dose-volume data representing multiple isotropic patient set-up uncertainties and range uncertainties (for proton therapy) are included to model dose delivery uncertainties. The model was retrospectively applied to an example patient as a demonstration. When uncertainty in the radiobiological model parameter was considered, the model predicted that proton therapy would result in an improved clinical outcome compared with X-ray therapy. However, when dose delivery uncertainty was included, there was no difference between the two treatments. By incorporating uncertainties in the predictive modelling calculations, the fuzzy Markov concept was found to be well suited to providing a more holistic comparison of individualised treatment outcomes for proton and X-ray therapy. This may prove to be useful in model-based patient selection strategies.
- 29 January 2018
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 41 (1) , 1-2
A positive move: proton therapy in Australia
- 29 January 2018
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 41 (1) , 1-2
A positive move: proton therapy in Australia
- 1 December 2017
- Published by Elsevier in Physica Medica
- Vol. 44, 72-82
A radiobiological Markov simulation tool for aiding decision making in proton therapy referral
- 1 December 2017
- Published by Elsevier in Physica Medica
- Vol. 44, 72-82
A radiobiological Markov simulation tool for aiding decision making in proton therapy referral
- 13 October 2017
- Published by Wiley in Medical Physics
- Vol. 44 (10) , 5537-5538
Reply to “Comment on ‘Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning’ [Med. Phys. 43(6), 2845-2854 (2016)]”
- 13 October 2017
- Published by Wiley in Medical Physics
- Vol. 44 (10) , 5537-5538
Reply to “Comment on ‘Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning’ [Med. Phys. 43(6), 2845-2854 (2016)]”
- 4 August 2017
- Published by Wiley in Medical Physics
- Vol. 44 (10) , 5143-5152
Europium‐155 as a source for dual energy cone beam computed tomography in adaptive proton therapy: A simulation study
To investigate the feasibility of a 3D imaging system utilizing a 155Eu source and pixelated cadmium-zinc-telluride (CZT) detector for applications in adaptive radiotherapy. Specifically, to compare the reconstructed stopping power ratio (SPR) values of a head phantom obtained with the proposed imaging technique with theoretical SPR values. A Geant4 Monte Carlo simulation was performed with the novel imaging system. The simulation was repeated with a typical 120 kV X-ray tube spectrum while maintaining all other parameters. Dual energy 155Eu source cone beam computed tomography (CBCT) images were reconstructed with an iterative projection algorithm known as total variation superiorization with diagonally relaxed orthogonal projections (TVS-DROP). Single energy 120 kV source CBCT images were also reconstructed with TVS-DROP. Reconstructed images were converted to SPR with stoichiometric calibration techniques based on ICRU 44 tissues. Quantitative accuracy of reconstructed attenuation coefficient images as well as SPR images were compared. Images generated by gamma emissions of 155Eu showed superior contrast resolution to those generated by the 120 kV spectrum. Quantitatively, all reconstructed images correlated with reference attenuation coefficients of the head phantom within 1 standard deviation. Images generated with the 155Eu source showed a smaller standard deviation of pixel values. Use of a dual energy conversion into SPR resulted in superior SPR accuracy with the 155Eu source. 155Eu was found to display desirable qualities when used as a source for dual energy CBCT. Further work is required to demonstrate whether the simulation results presented here can be translated into an experimental prototype.
- 4 August 2017
- Published by Wiley in Medical Physics
- Vol. 44 (10) , 5143-5152
Europium‐155 as a source for dual energy cone beam computed tomography in adaptive proton therapy: A simulation study
To investigate the feasibility of a 3D imaging system utilizing a 155Eu source and pixelated cadmium-zinc-telluride (CZT) detector for applications in adaptive radiotherapy. Specifically, to compare the reconstructed stopping power ratio (SPR) values of a head phantom obtained with the proposed imaging technique with theoretical SPR values. A Geant4 Monte Carlo simulation was performed with the novel imaging system. The simulation was repeated with a typical 120 kV X-ray tube spectrum while maintaining all other parameters. Dual energy 155Eu source cone beam computed tomography (CBCT) images were reconstructed with an iterative projection algorithm known as total variation superiorization with diagonally relaxed orthogonal projections (TVS-DROP). Single energy 120 kV source CBCT images were also reconstructed with TVS-DROP. Reconstructed images were converted to SPR with stoichiometric calibration techniques based on ICRU 44 tissues. Quantitative accuracy of reconstructed attenuation coefficient images as well as SPR images were compared. Images generated by gamma emissions of 155Eu showed superior contrast resolution to those generated by the 120 kV spectrum. Quantitatively, all reconstructed images correlated with reference attenuation coefficients of the head phantom within 1 standard deviation. Images generated with the 155Eu source showed a smaller standard deviation of pixel values. Use of a dual energy conversion into SPR resulted in superior SPR accuracy with the 155Eu source. 155Eu was found to display desirable qualities when used as a source for dual energy CBCT. Further work is required to demonstrate whether the simulation results presented here can be translated into an experimental prototype.
- 5 April 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (9) , 3599-3618
Sparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy
A split feasibility formulation for the inverse problem of intensity-modulated radiation therapy treatment planning with dose-volume constraints included in the planning algorithm is presented. It involves a new type of sparsity constraint that enables the inclusion of a percentage-violation constraint in the model problem and its handling by continuous (as opposed to integer) methods. We propose an iterative algorithmic framework for solving such a problem by applying the feasibility-seeking CQ -algorithm of Byrne combined with the automatic relaxation method that uses cyclic projections. Detailed implementation instructions are furnished. Functionality of the algorithm was demonstrated through the creation of an intensity-modulated proton therapy plan for a simple 2D C-shaped geometry and also for a realistic base-of-skull chordoma treatment site. Monte Carlo simulations of proton pencil beams of varying energy were conducted to obtain dose distributions for the 2D test case. A research release of the Pinnacle 3 proton treatment planning system was used to extract pencil beam doses for a clinical base-of-skull chordoma case. In both cases the beamlet doses were calculated to satisfy dose-volume constraints according to our new algorithm. Examination of the dose-volume histograms following inverse planning with our algorithm demonstrated that it performed as intended. The application of our proposed algorithm to dose-volume constraint inverse planning was successfully demonstrated. Comparison with optimized dose distributions from the research release of the Pinnacle 3 treatment planning system showed the algorithm could achieve equivalent or superior results.
- 5 April 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (9) , 3599-3618
Sparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy
A split feasibility formulation for the inverse problem of intensity-modulated radiation therapy treatment planning with dose-volume constraints included in the planning algorithm is presented. It involves a new type of sparsity constraint that enables the inclusion of a percentage-violation constraint in the model problem and its handling by continuous (as opposed to integer) methods. We propose an iterative algorithmic framework for solving such a problem by applying the feasibility-seeking CQ -algorithm of Byrne combined with the automatic relaxation method that uses cyclic projections. Detailed implementation instructions are furnished. Functionality of the algorithm was demonstrated through the creation of an intensity-modulated proton therapy plan for a simple 2D C-shaped geometry and also for a realistic base-of-skull chordoma treatment site. Monte Carlo simulations of proton pencil beams of varying energy were conducted to obtain dose distributions for the 2D test case. A research release of the Pinnacle 3 proton treatment planning system was used to extract pencil beam doses for a clinical base-of-skull chordoma case. In both cases the beamlet doses were calculated to satisfy dose-volume constraints according to our new algorithm. Examination of the dose-volume histograms following inverse planning with our algorithm demonstrated that it performed as intended. The application of our proposed algorithm to dose-volume constraint inverse planning was successfully demonstrated. Comparison with optimized dose distributions from the research release of the Pinnacle 3 treatment planning system showed the algorithm could achieve equivalent or superior results.
- Open Access
Sparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy
A split feasibility formulation for the inverse problem of intensity-modulated radiation therapy (IMRT) treatment planning with dose-volume constraints (DVCs) included in the planning algorithm is presented. It involves a new type of sparsity constraint that enables the inclusion of a percentage-violation constraint in the model problem and its handling by continuous (as opposed to integer) methods. We propose an iterative algorithmic framework for solving such a problem by applying the feasibility-seeking CQ-algorithm of Byrne combined with the automatic relaxation method (ARM) that uses cyclic projections. Detailed implementation instructions are furnished. Functionality of the algorithm was demonstrated through the creation of an intensity-modulated proton therapy plan for a simple 2D C-shaped geometry and also for a realistic base-of-skull chordoma treatment site. Monte Carlo simulations of proton pencil beams of varying energy were conducted to obtain dose distributions for the 2D test case. A research release of the Pinnacle3 proton treatment planning system was used to extract pencil beam doses for a clinical base-of-skull chordoma case. In both cases the beamlet doses were calculated to satisfy dose-volume constraints according to our new algorithm. Examination of the dose-volume histograms following inverse planning with our algorithm demonstrated that it performed as intended. The application of our proposed algorithm to dose-volume constraint inverse planning was successfully demonstrated. Comparison with optimized dose distributions from the research release of the Pinnacle3 treatment planning system showed the algorithm could achieve equivalent or superior results.
Open AccessSparsity constrained split feasibility for dose-volume constraints in inverse planning of intensity-modulated photon or proton therapy
A split feasibility formulation for the inverse problem of intensity-modulated radiation therapy (IMRT) treatment planning with dose-volume constraints (DVCs) included in the planning algorithm is presented. It involves a new type of sparsity constraint that enables the inclusion of a percentage-violation constraint in the model problem and its handling by continuous (as opposed to integer) methods. We propose an iterative algorithmic framework for solving such a problem by applying the feasibility-seeking CQ-algorithm of Byrne combined with the automatic relaxation method (ARM) that uses cyclic projections. Detailed implementation instructions are furnished. Functionality of the algorithm was demonstrated through the creation of an intensity-modulated proton therapy plan for a simple 2D C-shaped geometry and also for a realistic base-of-skull chordoma treatment site. Monte Carlo simulations of proton pencil beams of varying energy were conducted to obtain dose distributions for the 2D test case. A research release of the Pinnacle3 proton treatment planning system was used to extract pencil beam doses for a clinical base-of-skull chordoma case. In both cases the beamlet doses were calculated to satisfy dose-volume constraints according to our new algorithm. Examination of the dose-volume histograms following inverse planning with our algorithm demonstrated that it performed as intended. The application of our proposed algorithm to dose-volume constraint inverse planning was successfully demonstrated. Comparison with optimized dose distributions from the research release of the Pinnacle3 treatment planning system showed the algorithm could achieve equivalent or superior results.